Novo Nordisk weight-loss drug wins US approval as a daily pill



© Jennifer Reynolds/The Galveston County Daily News, via Associated Press

© The New York Times

© Stefan Rousseau/Press Association, via Associated Press























Food and Drug Administration’s approval hands drugmaker Novo Nordisk an edge in the race to market an obesity pill
US regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.
The US Food and Drug Administration’s approval handed drugmaker Novo Nordisk an edge over rival Eli Lilly in the race to market an obesity pill. Lilly’s oral drug, orforglipron, is still under review.
Continue reading...
© Photograph: Hollie Adams/Reuters

© Photograph: Hollie Adams/Reuters

© Photograph: Hollie Adams/Reuters


























Not everyone understands the spirit of Christmas
See more of Fiona Katauskas’s cartoons here

© Illustration: Fiona Katauskas/The Guardian

© Illustration: Fiona Katauskas/The Guardian

© Illustration: Fiona Katauskas/The Guardian
Church leaders and members detained as government tightens controls on underground Christian gatherings
The knocks came at 2am. Hiding out at a friend’s house in a Beijing suburb, Gao Yingjia and his wife, Geng Pengpeng, rushed downstairs to meet the group of plain-clothed men who said they were police officers. Their son, nearly six, was sleeping upstairs, and Gao and Geng wanted to minimise the ruckus. They knew their time was up.
Two months later, Gao is in a detention centre in Guangxi province, southern China, charged with “illegal use of information networks”. His arrest was part of the biggest crackdown on Christians in China since 2018. It has prompted alarm from the US government and human rights groups, with some analysts describing it as the death knell for unofficial churches in China.
Continue reading...
© Photograph: supplied

© Photograph: supplied

© Photograph: supplied




